Related Articles
Early sorafenib induction after transarterial chemoembolization for unresectable hepatocellular carcinoma: Can sorafenib after TACE improve loco‑regional control?
GALNT14 genotype, α‑fetoprotein and therapeutic side effects predict post‑chemotherapy survival in patients with advanced hepatocellular carcinoma
Efficacy and adverse events of transcatheter arterial chemoembolization in combination with sorafenib in the treatment of unresectable hepatocellular carcinoma
A single-center experience of sorafenib monotherapy in patients with advanced intrahepatic cholangiocarcinoma
Transarterial chemoembolization with/without cryotherapy is associated with improved clinical outcomes of sorafenib for the treatment of advanced hepatocellular carcinoma